Regional Biocontainment Laboratory

The Regional Biocontainment Laboratory at Duke was built with funding from NIH to support basic research to develop drugs, diagnostics, and vaccines for emerging and reemerging infections and biodefense. The RBL has a comprehensive safety and operations program to provide state-of-the-art biocontainment facilities for BSL2, BSL3, and Select Agent research. The RBL was fully-commissioned in late 2007 and has supported over 60 publications (NIAID UC6-AI058607).

To learn more about the Regional Biocontainment Laboratory, please visit: